Key facts
- It has raised $4.3M across 1 recorded rounds; the latest was Seed Round ($600K) in Jun 2024.
- Notable investors include Impact Assets, Precursor Ventures, Ulu Ventures, Capital F.
- Xella Health has filed 1 Form D with the SEC, most recently Dec 2024 ($600K sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Xella Health
Funding rounds
1 roundsAbout Xella Health
Developer of at-home diagnostic testing designed for early detection and monitoring of women's reproductive health conditions. The company's platform uses AI-powered analysis of menstrual fluid collected via tampon to evaluate molecular data across genomics, epigenomics, transcriptomics, proteomics, metabolomics, and exposomics, enabling individuals and clinicians to access personalized health insights, reduce diagnostic delays for conditions like endometriosis, and assess reproductive aging with accuracy and convenience.
- Sector
- Healthcare
- HQ
- Half Moon Bay, CA, United States
- Founded
- 2023
- Website
- joinxella.com/
- Ownership
- Privately Held (backing)
Xella Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xella Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xella Health in its N-PORT filings yet. We sweep new filings monthly.